Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: A Danish single center experience

Abstract

IFX is of long-term benefit as rescue treatment in selected patients with acute, severe UC with about two-thirds of the patients avoiding colectomy. The beneficial effect on colectomy rate in chronic, refractory UC seems less convincing although these patients may still achieve a sustained clinical response.